Edition

Flor M. Munoz

2

0

Associate Professor of Pediatric Infectious Diseases, Baylor College of Medicine

Expecting parents and those with infants have new options to consider to protect against RSV. martin-dm/E+ via Getty Images

August 28, 2023

FDA’s greenlighting of maternal RSV vaccine represents a major step forward in protecting young babies against the virus

Annette Regan, University of San Francisco and Flor M. Munoz, Baylor College of Medicine

Nearly 100,000 US children under age 5 are hospitalized each year for an RSV infection.

Only one antiviral medication is approved by the FDA for RSV treatment, and it is administered through a nebulizer. BonNontawat/iStock via Getty Images Plus

December 16, 2022

RSV treatments for young children are lacking, but the record 2022 cold and flu season highlights the urgency for vaccines and other preventive strategies

Annette Regan, University of San Francisco and Flor M. Munoz, Baylor College of Medicine

While RSV can become severe for any child, it poses a particularly serious threat for the youngest babies and for high-risk children.

Contact Flor for

General
Media request
Speaking request
Consulting / Advising
Research collaboration
Research supervision

Location: Houston, Texas, U.S.
Website
Article Feed
Joined November 30, 2022